Tax and M1 peptide/HLA-A2-specific Fabs and T cell receptors recognize nonidentical structural features on peptide/HLA-A2 complexes

Journal of Immunology

Volumn 171, Issue 6, 2003, Pages 3064-3074

  Biddison, William E ^a,c   Turner, Richard V ^a   Gagnon, Susan J ^a   Lev, Avital ^b   Cohen, Cyril J ^b   Reiter, Yoram ^b  

^a NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^b TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HLA A2 ANTIGEN; IMMUNOGLOBULIN F(AB) FRAGMENT; PEPTIDE; T LYMPHOCYTE RECEPTOR; TAX PROTEIN; UNCLASSIFIED DRUG;

ANTIGEN RECOGNITION; ARTICLE; B LYMPHOCYTE ACTIVATION; COMPLEX FORMATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN T CELL LEUKEMIA VIRUS; IMMUNE RESPONSE; MAJOR HISTOCOMPATIBILITY COMPLEX; NONHUMAN; PEPTIDE MI; PRIORITY JOURNAL; PROTEIN FUNCTION; STRUCTURE ANALYSIS; T LYMPHOCYTE ACTIVATION;

EID: 0042333429     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.171.6.3064     Document Type: Article

References (46)

1. Wilson, I., and R. Stanfield. 1993. Antibody-antigen interactions. Curr. Opin. Struct. Biol. 3:113.
2. Davis, M., J. Boniface, Z. Reich, D. Lyons, J. Hampl, B. Arden, and Y. Chien. 1998. Ligand recognition by αβ T cell receptors. Annu. Rev. Immunol. 16:523.
3. van Leeuwen, A., E. Goulmy, and J. J. van Rood. 1979. Major histocompatibility complex-restricted antibody reactivity mainly, but not exclusively, directed against cells from male donors. J. Exp. Med. 150:1075.
4. Wylie, D., L. Sherman, and N. Klinman. 1982. Participation of the major histocompatibility complex in antibody recognition of viral antigens expressed on infected cells. J. Exp. Med. 155:403.
5. Nygard, N., C. Bono, L. Brown, J. Gorka, K. Giacoletto, W. Schaiff, M. Graham, D. McCourt, M. Kabeer, V. Braciale, et al. 1991. Antibody recognition of an immunogenic influenza hemagglutinin-human leukocyte antigen class II complex. J. Exp. Med. 174:243.
6. Murphy, D., S. Rath, E. Pizzo, A. Rudensky, A. George, J. Larson, Jr., and C. Janeway. 1992. Monoclonal antibody detection of a major self peptide: MHC class II complex. J. Immunol. 148:3483.
7. Eastman, S., M. Deftos, P. DeRoos, D. Hsu, L. Teyton, N. Braunstein, C. Hackett, and A. Rudensky. 1996. A study of complexes of class II invariant chain peptide: major histocompatibility complex class II molecules using a new complex-specific monoclonal antibody. Eur. J. Immunol. 26:385.
8. Dadaglio, G., C. Nelson, M. Deck, S. Petzold, and E. Unanue. 1997. Characterization and quantitation of peptide-MHC complexes produced from hen egg lysozyme using a monoclonal antibody. Immunity 6:727.
9. Puri, J., R. Arnon, E. Gurevich, and D. Teitelbaum. 1997. Modulation of the immune response in multiple sclerosis: production of monoclonal antibodies specific to HLA/myelin basic protein. J. Immunol. 158:2471.
10. Porgador, A., J. Yewdell, Y. Deng, J. Bennink, and R. Germain. 1997. Localization, quantitation, and in situ detection of specific peptide-MHC class I complexes using a monoclonal antibody. Immunity 6:715.
11. Krogsgaard, M., K. Wucherpfennig, B. Canella, B. Hansen, A. Svejgaard, J. Pyrdol, H. Ditzel, C. Raine, J. Engberg, and L. Fugger. 2000. Visualization of myelin basic protein (MBP) T cell epitopes in multiple sclerosis lesions using a monoclonal antibody specific for the human leukocyte antigen (HLA)-DR2-MBP 85-99 complex. J. Exp. Med. 191:1395.
12. d complexed with an antigenic peptide: similarities to a T cell receptor with the same specificity. J. Immunol. 165:5703.
13. Garcia, K., M. Degano, R. Stanfield, A. Brunmark, M. Jackson, P. Peterson, L. Teyton, and I. Wilson. 1996. An αβ T cell receptor structure at 2.5 Å and its orientation in the TCR-MHC complex. Science 274:209.
14. Garboczi, D., P. Ghosh, U. Utz, Q. Fan, W. Biddison, and D. C. Wiley. 1996. Structure of the complex between human T-cell receptor, viral peptide and HLA-A2. Nature 384:134.
15. Garcia, K., M. Degano, L. Pease, M. Huang, P. Peterson, L. Teyton, and I. Wilson. 1998. Structural basis of plasticity in T cell receptor recognition of a self peptide-MHC antigen. Science 279:1166.
16. Ding, Y.-H., K. Smith, D. Garboczi, U. Utz, W. Biddison, and D. C. Wiley. 1998. Two human T cell receptors bind in a similar diagonal mode to the HLA-A2/Tax peptide complex using different TCR amino acids. Immunity 8:403.
17. Ding, Y.-H., B. M. Baker, D. Garboczi, W. Biddison, and D. C. Wiley. 1999. Four A6-TCR/peptide/HLA-A2 structures that generate very different T cell signals are nearly identical. Immunity 11:45.
18. Reinherz, E., K. Tan, L. Tang, P. Kern, J. Liu, Y. Xiong, R. Hussey, A. Smolyar, B. Hare, R. Zhang, et al. 1999. The crystal structure of a T cell receptor in complex with peptide and MHC class II. Science 286:1913.
19. Degano, M., K. Garcia, V. Apostolopoulos, M. Rudolph, L. Teyton, and I. Wilson. 2000. A functional hot spot for antigen recognition in a superagonist TCR/MHC complex. Immunity 12:251.
20. Reiser, J.-B., C. Darnault, A. Guimezanes, C. Gregoire, T. Mosser, A.-M. Schmitt-Verhulst, J. Fontecilla-Camps, B. Malissen, D. Housset, and G. Mazza. 2000. Crystal structure of a T cell receptor bound to an allogeneic MHC molecule. NatureImmunology 1:291.
21. Reiser, J.-B., C. Gregoire, C. Damault, T. Mosser, A. Guimezanes, A.-M. Schmitt-Verhulst, J. Fontecilla-Camps, G. Mazza, B. Malissen, and D. Housset. 2002. A T cell receptor CDR3β loop undergoes conformational changes of unprecedented magnitude upon binding to a peptide/MHC class I complex. Immunity 16:345.
22. Hennecke, J., and D. C. Wiley. 2002. Structure of a complex of the human α/β T cell receptor (TCR) HA1.7, influenza hemagglutinin peptide, and major histocompatibility complex class II molecule, HLA-DR4 (DRA*0101 and DRB1*0401): insight into TCR cross-restriction and alloreactivity. J. Exp. Med. 195:571.
23. Kjer-Nielsen, L., C. Clements, A. Purcell, A. Brooks, J. Whisstock, S. Burrows, J. McCluskey, and J. Rossjohn. 2003. A structural basis for the selection of dominant αβ T cell receptors in antiviral immunity. Immunity 18:53.
24. Hennecke, J., and D. C. Wiley. 2001. T cell receptor-MHC interactions up close. Cell 104:1.
25. + cytotoxic T lymphocytes from patients with HTLV-1-associated disease: evidence for oligoclonal expansion. J. Virol. 70:843.
26. Baker, B., R. Turner, S. Gagnon, D. C. Wiley, and W. Biddison. 2001. Identification of a crucial energetic footprint on the al helix of human histocompatibility leukocyte antigen (HLA)-A2 that provides functional interactions for recognition by Tax peptide/HLA-A2-specific T cell receptors. J. Exp. Med. 193:551.
27. Wang, Z. R. Turner, B. Baker, and W. Biddison. 2002. MHC allele-specific molecular features determine peptide/HLA-A2 conformations that are recognized by HLA-A2-restricted T cell receptors. J. Immunol. 169:3146.
28. 11-19-specific T cell clones in relationship to their MHC/peptide/ TCR crystal structures. J. Immunol. 162:5389.
29. Baker, B., Y.-H. Ding, D. Garboczi, W. Biddison, and D. C. Wiley. 2000. Structural, biochemical, and biophysical studies of HLA-A2/altered peptide ligands binding to viral peptide-specific human T-cell receptors. Cold Spring Harbor Symp. Quant. Biol. 64:235.
30. Baker, B. M., S. Gagnon, W. Biddison, and D. C. Wiley. 2000. Conversion of a T cell antagonist into an agonist by repairing a defect in the TCR/peptide/MHC interface: Implications for TCR signaling. Immunity 13:475.
31. Gotch, F., A. McMichael, and J. Rothbard. 1988. Recognition of influenza A matrix protein by HLA-A2-restricted cytotoxic T lymphocytes: use of analogues to orientate the matrix peptide in the HLA-A2 binding site. J. Exp. Med. 168:2045.
32. Sauma, S., M. Gammon, M. Bednarek, B. Cunningham, W. Biddison, J. Hermes, G. Porter, S. Tamhankar, J. Hawkins, B. Bush, et al. 1993. Recognition by HLA-A2-restricted cytotoxic T lymphocytes of endogenously generated and exogenously provided synthetic peptide analogues of the influenza A matrix protein. Hum. Immunol. 37:252.
33. Madden, D., D. Garboczi, and D. C. Wiley. 1993. The antigenic identity of peptide-MHC complexes: a comparison of the conformations of five viral peptides presented by HLA-A2. Cell 75:693.
34. Lev, A., G. Denkberg, C. Cohen, M. Tzukerman, K. Skorecki, P. Chames, H. Hoogenboom, and Y. Reiter. 2002. Isolation and characterization of human recombinant antibodies endowed with the antigen-specific, major histocompatibility complex-restricted specificity of T cells directed toward the widely expressed tumor T-cell epitopes of the telomerase catalytic subunit. Cancer Res. 62:3184.
35. Denkberg, G., C. Cohen, A. Lev, P. Chames, H. Hoogenboom, and Y. Reiter. 2002. Direct visualization of distinct T cell epitopes derived from a melanoma tumor-associated antigen by using human recombinant antibodies with MHC-restricted T cell receptor-like specificity. Proc. Natl. Acad. Sci. USA 99:9421.
36. Chames, P., S. Hufton, P. Coulie, B. Uchanska-Ziegler, and H. Hoogenboom. 2002. Direct selection of a human antibody fragment directed against the tumor T-cell epitope HLA-AI-MAGE-AI from a nonimmunized phage-Fab library. Proc. Natl. Acad. Sci. USA 97:7969.
37. Cohen, C., O. Sarig, Y. Yamano, U. Tomaru, S. Jacobson, and Y. Reiter. 2003. Direct phenotypic analysis of human MHC class I antigen presentation: visualization, quantitation, and in situ detection of human viral epitopes using peptide-specific, MHC-restricted TCR-like human recombinant antibodies. J. Immunol. 170:4349.
38. de Haard, H., N. v. Neer, A. Reurs, S. Hufton, R. Roovers, P. Henderikx, A. de Bruine, J.-W. Arends, and H. Hoogenboom. 1999. A large non-immunized human Fab fragment phage library that permits rapid isolation and kinetic analysis of high affinity antibodies. J. Biol. Chem. 274:18218.
39. Denkberg, G., E. Klechevsky, and Y. Reiter. 2002. Modification of a tumor-derived peptide at an HLA-A2 anchor residue can alter the conformation of the MHC-peptide complex: probing with TCR-like recombinant antibodies. J. Immunol. 169:4399.
40. Gotch, F., J. Rothbard, K. Howland, A. Townsend, and A. McMichael. 1987. Cytotoxic T lymphocytes recognize a fragment of influenza virus matrix protein in association with HLA-A2. Nature 326:881.
41. Kawakami, K., S. Eliyahu, K. Sakaguchi, P. Robbins, L. Rivoltini, J. Yannelli, E. Appella, and S. Rosenberg. 1994. Identification of the immunodominant peptides of the MART-1 human melanoma antigen recognized by the majority of HLA-A2-restricted tumor infiltrating lymphocytes. J. Exp. Med. 180:347.
42. Denkberg, G., C. Cohen, D. Segal, A. Kirkin, and Y. Reiter. 2000. Recombinant human single-chain MHC-peptide complexes and tetramers with tumor-associated antigens. Eur. J. Immunol. 60:3522.
43. Storkus, W., D. Howell, R. Salter, J. Dawson, and P. Cresswell. 1987. NK susceptibility varies inversely with target cell class I HLA antigen expression. J. Immunol. 138:1657.
44. Messaoudi, I., J. LeMaoult, and J. Nikolic-Zugic. 1999. The mode of ligand recognition by two peptide: MHC class I-specific monoclonal antibodies. J. Immunol. 163:3286.
45. Stryhn, A., P. Andersen, L. Pedersen, A. Svejgaard, A. Holm, C. Thorpe, L. Fugger, S. Buus, and J. Engberg. 1996. Shared fine specificity between T-cell receptors and an antibody recognizing a peptide/major histocompatibility class I complex. Proc. Natl. Acad. Sci. USA 93:10338.
46. Hoogenboom, H., and P. Chames. 2000. Natureal and designer binding sites made by phage display technology. Immunol. Today. 21:371.